Processa Pharmaceuticals, Inc.
PCSA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001533743
In the last 90 days, Processa Pharmaceuticals, Inc. insiders filed 5 open-market purchases and 0 sales; 12 institutions reported holding it in 13F filings for Q2 2026, worth $498.3K in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Processa Pharmaceuticals, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 18 | 18 | 0 |
| Shares | 1.37M | 1.43M | +56.1K (+4.1%) |
| Value | $11.2M | $12.2M | +$1.00M (+9.0%) |
New holders (2)
Institutions that held Processa Pharmaceuticals, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Verdence Capital Advisors LLC | 73,786 | $632.0K | 0.08% |
| Morgan Stanley | 68 | $1.00K | 0.00% |
Sold out (2)
Institutions that held Processa Pharmaceuticals, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Millennium Management LLC | 54,154 | $444.0K |
| Citadel Advisors LLC | 10,106 | $83.0K |